1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 14,570 | 14,800 | 22:15 | |
| 14,570 | 14,780 | 22:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.12.25 | emeis Raises €3.15 Billion in New Financing | 361 | Business Wire | Early refinancing of A/B/C/D bank debt
Early exit from the accelerated safeguard plan1
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218951889/en/... ► Artikel lesen | |
| 12.12.25 | De-leveraging continues: emeis sells its nursing home business in Switzerland for nearly €270 million | 378 | Business Wire | €2.4 billion in disposals now completed or secured since mid-2022
Regulatory News:
emeis (Paris:EMEIS)has finalized sales agreements with Tertianum, a Swiss operator specializing in care and... ► Artikel lesen | |
| 10.11.25 | emeis: Refinancing and Extension of Debt Maturity | 457 | Business Wire | Agreement in principle with emeis's main banking partners and financial investors, enabling early exit from the accelerated safeguard plan
Regulatory News:
This press release features multimedia.... ► Artikel lesen | |
| 03.11.25 | Emeis Q3 2025 presentation: Occupancy gains fuel 7% organic revenue growth | 6 | Investing.com | ||
| 03.11.25 | Earnings Call Transkript: Starke Q3-Zahlen beflügeln Emeis-Aktie | 11 | Investing.com Deutsch | ||
| 03.11.25 | emeis Sells Its Independent Senior Residences Business in France for Nearly €160 Million | 332 | Business Wire | Regulatory News:
On October 31, 2025, emeis (Paris:EMEIS) finalized the sale of its independent senior residences in France and related real estate to a real estate fund managed by TwentyTwo Real... ► Artikel lesen | |
| EMEIS Aktie jetzt für 0€ handeln | |||||
| 28.10.25 | emeis Société anonyme reports Q3 results | 4 | Seeking Alpha | ||
| 28.10.25 | emeis: Revenue and activity at the end of September 20251 | 400 | Business Wire | A solid third quarter confirming improvement in occupancy rates organic growth Increase in occupancy rates, particularly in nursing homes (France, Northern Europe, Central Europe) Organic... ► Artikel lesen | |
| 15.10.25 | Emeis H1 2025 slides: EBITDA surges 79% as healthcare provider shows strong recovery | 19 | Investing.com | ||
| 07.10.25 | emeis: Results for the first half of 2025 | 746 | Business Wire | Confirmed recovery trajectory
Free Cash Flow turned positive
Disposals targets now exceeded
New mid term outlook
Regulatory News:
This press release features multimedia. View the full release... ► Artikel lesen | |
| 03.10.25 | emeis: Availability of the 2025 Half-Year Financial Report | 630 | Business Wire | Regulatory News:
emeis (Paris:EMEIS) filed, today, its half-year financial report for the period starting on 1 January 2025 and ending on 30 June 2025, with the French Autorité des Marchés Financiers
The... ► Artikel lesen | |
| 24.09.25 | Emeis-Aktie springt nach oben: Immobiliengeschäft soll Nettoverschuldung um 700 Mio. Euro reduzieren | 6 | Investing.com Deutsch | ||
| 24.09.25 | Emeis stock surges after real estate deal to cut debt by €700 million | 1 | Investing.com | ||
| 23.09.25 | emeis: Disposal Target Exceeded and Reduction of Net Debt by Nearly €700 Million | 695 | Business Wire | Creation by emeis of a real estate company dedicated to healthcare real estate in Europe
Regulatory News:
Farallon Capital as lead investor, and TwentyTwo Real Estate, have today committed... ► Artikel lesen | |
| 31.07.25 | Emeis H1 2025 slides reveal accelerating recovery and disposal progress | 9 | Investing.com | ||
| 30.07.25 | emeis: Sales and Business Update at the End of June 20251 | 896 | Business Wire | Sustained growth in operating margins
Sustained revenue growth
+6.2% on a like-for-like basis
Net operational recovery
EBITDAR up nearly +20% on a like-for-like basis
EBITDA (excluding... ► Artikel lesen | |
| 21.07.25 | emeis S.A.: emeis: Half-Year Review (H1 2025) of the Liquidity Agreement Entered Into With Natixis ODDO BHF | 978 | Business Wire | Regulatory News:
Under the liquidity agreement entrusted by emeis S.A. (the "Company") (Paris:EMEIS) to Natixis ODDO BHF, the following resources were recorded in the dedicated liquidity account... ► Artikel lesen | |
| 26.06.25 | emeis 2025 Annual General Meeting | 773 | Business Wire | Summary of Voting Results
Regulatory News:
emeis (Paris:EMEIS):
Guillaume Pepy, Chairman of the Board of Directors:"Today, we are particularly proud to announce, together with the Board... ► Artikel lesen | |
| 21.05.25 | emeis S.A.: emeis: Documents and Information Related to the Combined General Meeting of 26 June 2025 | 1.061 | Business Wire | Regulatory News:
The Combined General Meeting (Ordinary and Extraordinary) of Shareholders of emeis S.A. (Paris:EMEIS) (the Company ») will be held on Thursday 26 June 2025 at 9:30 a.m. (Paris... ► Artikel lesen | |
| 12.05.25 | emeis: Sales and business to end-March 20251 | 910 | Business Wire | Further rise in occupancy rates in France and abroad Occupancy rates growth, particularly in nursing homes (France, Northern Europe, Central Europe) Organic sales growth of +6.2%2, Occupancy... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| UNITEDHEALTH | 298,05 | +1,85 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| DRAEGERWERK | 73,90 | +1,09 % | DRAEGERWERK AG & CO KGAA ST zeigt strukturelle Stärke | ||
| MEDTRONIC | 85,28 | -0,15 % | Medtronic Benefits Are Built for Every Chapter | Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare... ► Artikel lesen | |
| GERRESHEIMER | 27,300 | -1,44 % | Gerresheimer AG: Die Klarheit in der Rechnungslegung verbessert sich, aber die Vertrauenslücke bleibt bestehen. HALTEN. | Gerresheimer (GXI) hat das Kapitel der Bill-and-Hold-Buchhaltung abgeschlossen, indem etwa 28 Millionen EUR an Umsätzen für das Geschäftsjahr 2024 vollständig korrigiert wurden, nachdem eine von der... ► Artikel lesen | |
| INTUITIVE SURGICAL | 502,40 | -0,97 % | Is ISRG Stock Still A Buy At $600? | ||
| THERMO FISHER | 520,10 | -1,55 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| TELADOC HEALTH | 6,496 | +0,15 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| STRATEC | 22,050 | -1,12 % | Aktien Frankfurt: Dax vorweihnachtlich träge | FRANKFURT (dpa-AFX) - Nach den moderaten Gewinnen am Freitag ist der deutsche Aktienmarkt etwas schwächer in die kurze Handelswoche vor Weihnachten gestartet. Das Geschehen ist von einem deutlich geringeren... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,080 | -1,09 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 27,440 | +2,39 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten |
Das Unternehmen EMEIS kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 14,460 Euro und damit +2,19 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EMEIS finden Sie auf Wallstreet Online.